Patrick Daly

DocwireNews

Researchers assessed over 17,000 patient samples analyzed by targeted next generating sequencing (NGS) to discern the somatic mutation status of myeloid neoplasms. The results were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
In this study, 17,181 clinical samples were analyzed and results were applied to cohorts specific to acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN).
According to the researchers, led by Taylor J. Jenson and colleagues, DNA was extracted and assessed by a targeted NGS panel to pinpoint and detail single nucleotide variants and small indels within 50 genes associated with myeloid malignancies.
According to the results, 34,581 Tier I, II, or III somatic variants were detected, and an increased number of variants was associated with age and observed to be highest in AML patients.
“This study shows that parallel testing of multiple genes in addition to the canonical driver mutations encompasses the mutations contributing to the etiology of these diseases,” the researchers concluded. They added that: “Despite the breadth of different mutations observed for myeloid neoplasms, consistent patterns are routinely observed that can help the clinician tailor the treatment and chart the progression of these diseases for each patient.”

Laura Litwin

Are There Gender Disparities in Lung Cancer Screening Outcomes Among People Who Have Never Smoked?

Lung Cancer

Thomas Ruggia

Rob Dillard

Study Shows Positive Data for Implantable Telescope for Late-Stage Age-Related Macular Degeneration

Ophthalmology

Amber Sanchez, MD

Charlotte Robinson

Apheresis in Nephrology Practice

Nephrology Times

Latest News

Analyzing Mutations in Over 17,000 Patients With Myeloid Malignancies

ASCO 2022

Researchers assessed over 17,000 patient samples analyzed by targeted next generating sequencing (NGS) to discern the somatic mutation status of myeloid neoplasms. The results ...

Analyzing Mutations in Over 17,000 patients with Myeloid Malignancies

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe